Form D · Pharmaceuticals
UPPI, LLC
Suwanee, GA · CIK 0001517437
Offering snapshot reported Apr 5, 2011 · SEC filing
- Reported sold
- $105K Offering amount: $1.2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- Mar 21, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2011 | Initial | $105,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-157863
MEMBERSHIP INTERESTS
Source: Form D, filed Apr 5, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Brower | Director, Executive |
| Lamar Foti | Director |
| Raleigh Hamilton | Director, Executive |
| Perry Polsinelli | Executive |
| Rodney Prosser | Director |
| Stephen Putnal | Director |
| Richard Sheriff | Director, Executive |
| Tom Wilkinson | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5400 Laurel Springs Parkway, #405
Suwanee, GA, 30024
Suwanee, GA, 30024